Trial Outcomes & Findings for Falls in Older Persons With Limb Loss (NCT NCT03670004)

NCT ID: NCT03670004

Last Updated: 2022-11-07

Results Overview

Foot clearance of self-selected normal and fast speed walking, calculated as the distance (cm) between the toe and ground as measured with an optical motion capture system.

Recruitment status

COMPLETED

Target enrollment

23 participants

Primary outcome timeframe

1 month

Results posted on

2022-11-07

Participant Flow

Participant milestones

Participant milestones
Measure
Unilateral Below Knee Amputation
Individuals who walk with a below knee prosthesis
Non-Impaired
Able-bodied controls
Overall Study
STARTED
13
10
Overall Study
COMPLETED
13
10
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Falls in Older Persons With Limb Loss

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Unilateral Below Knee Amputation
n=13 Participants
Individuals who walk with a below knee prosthesis
Non-Impaired
n=10 Participants
Able-bodied controls
Total
n=23 Participants
Total of all reporting groups
Age, Continuous
71.1 years
STANDARD_DEVIATION 3.8 • n=5 Participants
71.7 years
STANDARD_DEVIATION 4.2 • n=7 Participants
71.4 years
STANDARD_DEVIATION 3.9 • n=5 Participants
Sex: Female, Male
Female
3 Participants
n=5 Participants
5 Participants
n=7 Participants
8 Participants
n=5 Participants
Sex: Female, Male
Male
10 Participants
n=5 Participants
5 Participants
n=7 Participants
15 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
13 Participants
n=5 Participants
10 Participants
n=7 Participants
23 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants
Race (NIH/OMB)
White
11 Participants
n=5 Participants
8 Participants
n=7 Participants
19 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
13 Participants
n=5 Participants
10 Participants
n=7 Participants
23 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 1 month

Population: Foot clearance was measured for each limb at each walking speed

Foot clearance of self-selected normal and fast speed walking, calculated as the distance (cm) between the toe and ground as measured with an optical motion capture system.

Outcome measures

Outcome measures
Measure
Unilateral Below Knee Amputation
n=26 Limbs
Individuals who walk with a below knee prosthesis
Non-Impaired
n=20 Limbs
Able-bodied controls
Foot's Height During the Swing Phase of Walking (i.e., Foot Clearance) Measured in Centimeter
Non-dominant/Impaired, normal speed
6.1 cm
Standard Deviation 1.5
5.5 cm
Standard Deviation 1.2
Foot's Height During the Swing Phase of Walking (i.e., Foot Clearance) Measured in Centimeter
Dominant/Sound, normal speed
6.1 cm
Standard Deviation 1.3
5.7 cm
Standard Deviation 1.3
Foot's Height During the Swing Phase of Walking (i.e., Foot Clearance) Measured in Centimeter
Non-dominant/Impaired, fast speed
5.1 cm
Standard Deviation 1.2
4.1 cm
Standard Deviation 0.8
Foot's Height During the Swing Phase of Walking (i.e., Foot Clearance) Measured in Centimeter
Dominant/Sound, fast speed
4.7 cm
Standard Deviation 0.7
4.2 cm
Standard Deviation 0.9

PRIMARY outcome

Timeframe: 1 month

Population: Sway area was measured for each limb for each vision condition of eyes open or closed

Center of pressure sway area during eyes open or closed, calculated as the area (cm\*cm) covered by the center of pressure position during standing as measured with a force plate.

Outcome measures

Outcome measures
Measure
Unilateral Below Knee Amputation
n=26 limbs
Individuals who walk with a below knee prosthesis
Non-Impaired
n=20 limbs
Able-bodied controls
Center of Pressure Sway Area During Eyes Open or Closed as Measured Through a Force Plate During Standing and Calculated as Centimeters Squared
Non-dominant/Impaired, eyes open
0.66 cm*cm
Standard Deviation 0.48
0.71 cm*cm
Standard Deviation 0.67
Center of Pressure Sway Area During Eyes Open or Closed as Measured Through a Force Plate During Standing and Calculated as Centimeters Squared
Dominant/Sound, eyes open
1.26 cm*cm
Standard Deviation 1.12
0.99 cm*cm
Standard Deviation 1.39
Center of Pressure Sway Area During Eyes Open or Closed as Measured Through a Force Plate During Standing and Calculated as Centimeters Squared
Dominant/Sound, eyes closed
1.22 cm*cm
Standard Deviation 0.94
0.79 cm*cm
Standard Deviation 0.80
Center of Pressure Sway Area During Eyes Open or Closed as Measured Through a Force Plate During Standing and Calculated as Centimeters Squared
Non-dominant/Impaired, eyes closed
0.64 cm*cm
Standard Deviation 0.43
0.76 cm*cm
Standard Deviation 0.81

PRIMARY outcome

Timeframe: 1 month

Population: Integrated EMG was measured for each muscle group of interest at each walking speed

Integrated Electromyography patterns of leg muscles during self-selected normal and fast speed walking as a proxy measure of muscle effort, calculated from integrating the muscle activity measured by sensors as voltage over time (mv\*sec)

Outcome measures

Outcome measures
Measure
Unilateral Below Knee Amputation
n=26 Muscle group
Individuals who walk with a below knee prosthesis
Non-Impaired
n=20 Muscle group
Able-bodied controls
Gait Muscle Activation Effort as Measured by Sensors and Integrating Measured Voltage With Respect to Time as to be Calculated as Millivolts Times Seconds
Dominant/Sound Tibilias Anterior, normal speed
0.278 mv*sec
Standard Deviation 0.069
0.306 mv*sec
Standard Deviation 0.067
Gait Muscle Activation Effort as Measured by Sensors and Integrating Measured Voltage With Respect to Time as to be Calculated as Millivolts Times Seconds
Dominant/Sound Tibilias Anterior, fast speed
0.372 mv*sec
Standard Deviation 0.096
0.348 mv*sec
Standard Deviation 0.098
Gait Muscle Activation Effort as Measured by Sensors and Integrating Measured Voltage With Respect to Time as to be Calculated as Millivolts Times Seconds
Dominant/Sound Gastroc, normal speed
0.360 mv*sec
Standard Deviation 0.041
0.256 mv*sec
Standard Deviation 0.079
Gait Muscle Activation Effort as Measured by Sensors and Integrating Measured Voltage With Respect to Time as to be Calculated as Millivolts Times Seconds
Dominant/Sound Gastroc, fast speed
0.307 mv*sec
Standard Deviation 0.063
0.318 mv*sec
Standard Deviation 0.123

SECONDARY outcome

Timeframe: 1 year

Population: Total number of falls 12 months prospectively

Number of falls during 12 months prospectively

Outcome measures

Outcome measures
Measure
Unilateral Below Knee Amputation
n=13 Participants
Individuals who walk with a below knee prosthesis
Non-Impaired
n=10 Participants
Able-bodied controls
Falls
18 Falls
10 Falls

Adverse Events

Unilateral Below Knee Amputation

Serious events: 1 serious events
Other events: 0 other events
Deaths: 0 deaths

Non-Impaired

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Unilateral Below Knee Amputation
n=13 participants at risk
Individuals who walk with a below knee prosthesis
Non-Impaired
n=10 participants at risk
Able-bodied controls
General disorders
Head Injury
7.7%
1/13 • Number of events 1 • 12 months prospectively
Any untoward or unfavorable medical occurrence in a participant, including any abnormal sign (for example, abnormal physical exam or laboratory finding), symptom, or disease, temporally associated with the participant's participation in the research, whether or not considered related to the participant's participation in the research.
0.00%
0/10 • 12 months prospectively
Any untoward or unfavorable medical occurrence in a participant, including any abnormal sign (for example, abnormal physical exam or laboratory finding), symptom, or disease, temporally associated with the participant's participation in the research, whether or not considered related to the participant's participation in the research.

Other adverse events

Adverse event data not reported

Additional Information

Dr. Matthew Major

Jesse Brown VA Medical Center

Phone: 312-503-5731

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place